Sleep Quality After Cesarean Delivery

December 16, 2025 updated by: Mahidol University

Sleep Quality After Cesarean Delivery Under Spinal Anesthesia With Intrathecal Morphine and Related Factors

Surgery causes poor sleep quality for several reasons eg. increasing stress hormonal production, pain, starvation, and environmental procedure namely noise, light, and nursing procedures. Poor sleep quality also brings numerous side effects including delirium, delayed recovery, and affect breastfeeding. We, therefore, aim to elucidate the incidence of poor sleep quality in parturients undergoing cesarean delivery in the early postoperative period and investigate the factors involving poor sleep conditions.

Study Overview

Detailed Description

Surgery causes poor sleep quality for several reasons eg. increasing stress hormonal production, pain, starvation, and environmental procedure namely noise, light, and nursing procedures. Postoperative pain after cesarean delivery can be found as high as 70 percent in the first postoperative pain. Also, the side effect of anesthetic may cause poor sleep quality such as itching, nausea, and vomiting.

Poor sleep quality brings numerous side effects including delirium, delayed recovery, and affect breastfeeding. The data on obstetric patients sleep quality in the early postoperative period is scarce. We, therefore, aim to elucidate the incidence of poor sleep quality in parturients undergoing cesarean delivery in the early postoperative period and investigate the factors involving poor sleep conditions.

Study Type

Observational

Enrollment (Actual)

286

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bangkok, Thailand, 10700
        • Anesthesiology department, Siriraj hospital, Mahidol University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Parturients age >,= 18 years old undergoing cesarean delivery

Description

Inclusion Criteria:

  • Age >,= 18 years, undergoing cesarean delivery
  • Receive spinal anesthesia with local anesthetic drug and intrathecal morphine
  • Understand Thai

Exclusion Criteria:

  • Patients receive epidural block or nerve block
  • Patients require conversion to general anesthesia with any reasons
  • Patients require endotracheal intubation with any reasons
  • Patients admit to intensive care unit in postoperative period
  • Patients with the end of operation at the time 24.00-6.00 AM

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sleep quality
Time Frame: 24 hours postoperative
Sleep quality at the first postoperative day evaluated by Richard Campbell Sleep Questionaire- Thai version
24 hours postoperative

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Nausea and vomiting score
Time Frame: 24 hours postoperative
Nausea and vomiting score; 0 = no symptom, 1= mild symptom nausea and no vomiting, 2 = vomiting 1-2 times, 3 = severe vomiting or needed treatment
24 hours postoperative
Itching
Time Frame: 24 hours postoperative
Itching score; 0 = no itching, 1= mild itching, 2 = severe itching or needed treatment
24 hours postoperative
Postoperative pain
Time Frame: 24 hours postoperative
11-point Numerical rating score (NRS) pain scale ranging from 0-10, 0= no pain, 10 = severe pain
24 hours postoperative
EQ-5D-5L
Time Frame: 24 hours postoperative
Quality of life evaluated by EuroQol group-5 Dimentions-5 levels questionnaire (EQ-5D-5L)- Thai version
24 hours postoperative
LATCH score
Time Frame: 24 hours postoperative and at the discharge day
LATCH score comprise of 5 components: Latch, Audible swallowing, Type of nipple, Comfort and Hold- each component scored from 0-2, A total of less than 8 is considered unsatisfactory
24 hours postoperative and at the discharge day
Length of hospital stay
Time Frame: Through the study completion an average 3-5 days
Length of hospital stay
Through the study completion an average 3-5 days
Neonatal weight
Time Frame: Postoperative day 1 and day 3
The weight of neonate
Postoperative day 1 and day 3

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Patchareya Nivatpumin, M.D., Department of Anesthesiology, Faculty of Medicine Siriraj Hospital, Mahidol University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 14, 2023

Primary Completion (Actual)

May 15, 2024

Study Completion (Actual)

May 15, 2024

Study Registration Dates

First Submitted

January 26, 2023

First Submitted That Met QC Criteria

March 3, 2023

First Posted (Actual)

March 7, 2023

Study Record Updates

Last Update Posted (Actual)

December 22, 2025

Last Update Submitted That Met QC Criteria

December 16, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 831/2565(IRB1)
  • Si 898/2022 (Registry Identifier: Siriraj Institutional Review Board)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

The data-sharing plan is undecided.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sleep Disturbance

Subscribe